| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-15 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-10 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 9e-08 |